Boeing (BA): Added to Position

On Monday, Boeing (BA) lost support and dropped through my price target which filled with a buy order at $203.41. Despite being the absolute biggest loser of the portfolio in 2020, I believe BA has some significant prospects in 2021 having gotten its top-selling plane, the 737-Max, back in the airspace’s good graces and with China in desperate need of new jets (plus, the need to look good to a new U.S. administration) the prospects of new orders to replace aging fleets is high.

Boeing is my biggest all-time winner, having earned in more realized gains than any position in the portfolio, so I have no problem adding in here, down -16.66% from its recent $244.08 high, even though my last buy was -37.57% lower from here on May 4 at $126.99.

Monday’s buy replaces a few of the shares I took profits on from September 2018 to May 2019 at an average price of $369.67, capturing +44.98% in gains on the difference between what I sold the shares for and the $203.41 where I’m buying them back. The buy also “raises” my per-share cost +10.42% from -$372.32 to -$333.52 (the negative per-share price means each share I hold of Boeing cost the portfolio no capital and, in fact, adds $333.52 in realized profits to the bottom line).

From here, my next price target to add more is $178.75 and I won’t be reducing the position until Boeing approaches its all-time high near $450. (Yes, I’m a loooonggg-term investor when it comes to Boeing, having initially opened the position on February 14, 2012 at $79.58)

BA closed the week at $194.19, down -4.53% from where I added Monday.

GW Pharmaceuticals (GWPH): Profit-Taking

GW Pharmaceuticals (GWPH) once again made its way into the $140s on Monday, triggering a sell order I had in place to reduce the position which filled with a sell order at $143.55.

Instead of following its range-bound trading between the low $110s and low $140s, GWPH rocketed higher on Wednesday, triggering a second sell order I had in place which filled at $162.26, giving me an average selling price of $152.90.

The combined sales lowered my per-share cost -22.61% from $91.10 to $70.50, and locked in +67.84% in gains.

I still have long-range goals for this stock, so my next selling price target is $174.25. I won’t add back into it unless it drops back below $90, a feat it just did a few months ago.

GWPH closed the week at $152.47, down -0.28% from my average selling price.

Square (SQ): Added to Position

Much like many of the other stocks in this portfolio, Square (SQ) has been trading in a range between slightly under $210 and slightly over $240 for the past few weeks and months. Accordingly, I added back into the position on Monday when SQ triggered a buy order that filled at $215.92.

The buy replaced shares I sold for $241.69 back on December 22, 2020 and locked in +10.66% in gains. It also “raised” my per-share cost for the position +8.90% from -$153.80 to -$140.11 (each share in the portfolio costs no capital and actually adds $140.11 in profits to the bottom line).

From here, my next buy target is $198.25, a past point of support, and my next sell target is near $250.

SQ closed the week at $215.96, up $0.04 from where I added Monday.